Page last updated: 2024-09-04

carbapenems and piperacillin, tazobactam drug combination

carbapenems has been researched along with piperacillin, tazobactam drug combination in 87 studies

Compound Research Comparison

Studies (carbapenems)	Trials (carbapenems)	Recent Studies (post-2010) (carbapenems)	Studies (piperacillin, tazobactam drug combination)	Trials (piperacillin, tazobactam drug combination)	Recent Studies (post-2010) (piperacillin, tazobactam drug combination)
7,355	147	5,277	1,263	136	914

Research

Studies (87)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.15)	18.2507
2000's	6 (6.90)	29.6817
2010's	46 (52.87)	24.3611
2020's	34 (39.08)	2.80

Authors

Authors	Studies
Mokaddas, EM; Sanyal, SC	1
Powell, LL; Wilson, SE	1
Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA	1
Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I	1
MacDougall, C; Oinonen, M; Pakyz, AL; Polk, RE	1
Restrepo, MI	1
Bahram, F; Emaneini, M; Fatolahzadeh, B; Feizabadi, MM; Mehdi, FM; Mohammad, E; Morovat, T; Setareh, S; Soroush, S; Taherikalani, M	1
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC	1
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY	1
Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N	1
Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF	1
Appelbaum, PC; Armstrong, ES; Kosowska-Shick, K; Kubo, A; Lin, G; Pankuch, GA	1
Adam, HJ; DeCorby, M; Hoban, DJ; Karlowsky, JA; Rennie, R; Zhanel, GG	1
Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH	1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW	1
Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y	1
Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB	1
Doi, Y; Qureshi, ZA	1
Wu, H; Xie, W; Ye, Z; Zhang, W; Zhao, C	1
Chen, YH; Chu, FY; Chuang, YC; Hsueh, PR; Huang, CC; Ko, WC; Liao, CH; Sheng, WH; Tang, HJ; Tsai, HY	1
Avdic, E; Cosgrove, SE; Han, JH; Harris, AD; Hsu, AJ; Lautenbach, E; Rock, C; Tamma, PD	1
Hong, MT; Seifert, CF	1
Hara, T; Horiyama, T; Izawa, M; Kanazawa, S; Maki, H; Sato, T; Tsuji, M; Yamaguchi, T	1
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S	1
Azouri, T; Bathina, P; Kandipalli, D; Kaplansky, T; Kaye, KS; Lazarovitch, T; Marchaim, D; Maskit, M; Ofer-Friedman, H; Sharma, S; Shefler, C; Tal-Jasper, R; Tirosh, A; Zaidenstein, R	1
Hirose, Y; Ishikawa, H; Kamata, K; Kanemoto, K; Shiotani, S; Suzuki, H; Suzuki, M; Tokuda, Y	1
Arah, OA; Chow, AL; Lye, DC	1
Chow, A; De, PP; Harris, PN; Khong, WX; Lye, DC; Ng, TM; Tambyah, PA	1
Higuchi, H; Horikoshi, Y; Isogai, M; Ito, K; Shoji, T; Suwa, J	1
Mikamo, H; Sugimoto, N; Yamagishi, Y	1
Bernatoniene, J; Bielicki, JA; Doerholt, K; Gharbi, M; Goossens, H; Heginbothom, M; Lyall, H; Menson, E; Patel, SV; Paulus, S; Riordan, A; Sharland, M; Vergnano, S; Versporten, A	1
Goldstein, EJ; Harrell, L; Hecht, DW; Jacobus, NV; Jenkins, SG; McDermott, LA; Newton, D; Patel, R; Snydman, DR	1
Eng, LC; Kwang, LL; Ng, LS; Rao, S; Tan, TY	1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF	1
Li, B; Li, L; Peters, BM; Shirtliff, ME; Xie, J; Xu, Z; Yu, G	1
Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ	1
Ang, BS; Ling, LM; Lye, DC; Ng, TM; Phang, VY; Tan, MW; Tan, SH; Tay, HL; Teng, CB; Young, B	1
Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK	1
Reyes, S; Schuetz, AN; Tamma, PD	1
Alfandari, S; Bertrand, X; Dumartin, C; Gauzit, R; Gbaguidi-Haore, H; Muller, A; Péfau, M; Rogues, AM	1
Kato, M; Matsuoka, T; Mori, T; Ohashi, K; Shinoda, Y; Tachi, T; Teramachi, H; Yoshida, S; Yoshimura, T	1
Ashiru-Oredope, D; Budd, E; Hopkins, S; Howard, P; Islam, J; Llewelyn, MJ; Walker, AS	1
Ashhurst-Smith, C; Ferguson, JK; Hughes, C	1
Chai, LYA; Chee, YL; Chng, WJ; Hsu, LY; Jin, J; Khoo, AL; Koh, LP; Lim, BP; Lim, SE; Poon, LM; Teng, M; Ying, D; Zhao, YJ	1
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G	1
Hagiwara, D; Kamada, M; Kamimura, H; Miyazaki, M; Moriwaki, N; Nakano, T; Sato, K; Shiotsuka, S; Takata, T; Togawa, A; Toh, H; Tokushige, C	1
Al Zaibag, M; Aljohany, SM; Alothman, AF; Arabi, YM; Baharoon, S; Balkhy, HH; El-Metwally, A; El-Saed, A	1
Cho, SY; Chung, DR; Kang, CI; Kim, SH; Ko, JH; Lee, NY; Peck, KR; Song, JH	1
Aitken, E; Gould, IM; Hijazi, K; Joshi, C; Oggioni, MR; Zamudio, R	1
DePestel, DD; DeRyke, CA; Gupta, V; Merchant, S; Murray, J; Puzniak, L; Srinivasan, A; Ye, G	1
Achiam, MP; Andersen, JS; Frimodt-Møller, N; Jonsson, AB; Møller, MH; Perner, A; Petersen, MW; Sjövall, F; Steensen, M	1
Hagiya, H; Hamaguchi, S; Kokado, R; Morii, D; Okuno, H; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H	1
Akata, K; Kawanami, T; Kido, T; Mukae, H; Muratani, T; Naito, K; Noguchi, S; Yamasaki, K; Yatera, K	1
Alfandari, S; Bleibtreu, A; Bru, JP; Chavanet, P; Gauzit, R; Lescure, X; Lesprit, P; Tattevin, P	1
David, SSB; Maor, Y; Schwartz, O; Yossepowitch, O; Zohar, I	1
Cheok, SJH; Chew, KL; Heng, ST; Lye, DC; Ng, TM; Ng, WHW; Tambyah, PA; Tan, SH; Wan, S; Wu, JE; Yap, MY; Yong, J	1
Decousser, JW; Fihman, V; Lepeule, R; Royer, G; Woerther, PL	1
Lai, CC; Wang, JH	1
Akazawa, M; Fukuda, H; Mimura, W	1
Cao, Y; Chen, L; Chen, T; Liu, H; Wang, L; Yang, C; Zhou, W	1
Asai, K; Fujita, A; Imoto, W; Kakeya, H; Kaneko, Y; Kawaguchi, T; Kuwabara, G; Nakaie, K; Niki, M; Okada, Y; Shibata, W; Watanabe, T; Yamada, K; Yamairi, K; Yoshii, N; Yukawa, S	1
Igari, H; Kawasakis, Y; Takayanagi, S; Taniguchi, T; Yahaba, M; Yamagishi, K; Yamazaki, S	1
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A	1
Academia, EC; Jenrette, JE; McLaughlin, JM; Mueller, SW	1
Heo, BY; Jo, DY; Kwon, J; Lee, HJ; Lee, MW; Ryu, H; Song, IC; Yeon, SH; Yun, HJ	1
Andini, R; Boccia, F; Corcione, A; De Rosa, R; Durante-Mangoni, E; Gagliardi, M; Karruli, A; Murino, P; Patauner, F; Ruocco, G; Sommese, P; Ursi, MP; Zampino, R	1
Al Dhahri, F; Al Enazi, H; Al Muqati, H; Al Turaiki, A; Althemery, A	1
Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Ohashi, W; Sakanashi, D; Shibata, Y; Shiota, A; Suematsu, H; Watanabe, H; Yamagishi, Y	1
Atsuda, K; Azuma, S; Hoshiyama, T; Inagaki, R; Komatsu, T; Mochida, S; Nihonyanagi, S; Sato, Y; Seto, Y; Takayama, Y; Wada, T	1
Braun-Feldweg, J; Germer, CT; Lock, JF; Meyer-Sautter, P; Rüsch, J; Surat, G	1
Edström, M; Hanberger, H; Sjövall, F; Walther, S	1
Bauer, MJ; Flora, MS; Forde, BM; Habib, ZH; Harris, P; Islam, K; Roberts, JA; Shirin, T; Sime, FB; Wallis, SC	1
Chang, H; Lee, CM; Lee, MC; Lu, CH; Sun, FJ; Wu, AY	1
Doi, Y; Enokida, T; Harada, S; Hayama, B; Hoashi, K; Ohkushi, D; Sakurai, A; Suzuki, M; Takeda, K; Takehana, K	1
Bouza, E; Burillo, A	1
Artacho, MJ; Cantón, R; Guzmán-Puche, J; Hernández-García, M; Kieffer, N; Martinez-Martinez, L; Pedraza, R; Pitart, C; Vila, J	1
Haines, RR; Hammer, KA; Putsathit, P; Tai, AS	1
Maseda, E; Suárez de la Rica, A	1
Gill, CM; Nicolau, DP	1
Banaei, N; Bounthavong, M; Deresinski, S; Diep, C; Ha, D; Lu, B; Wong, M	1
Achiam, MP; Andersen, JS; Granholm, A; Helleberg, M; Hertz, FB; Jonsson, AB; Munch, MW; Møller, MH; Perner, A; Sjövall, F; Steensen, M	1
Gueneau, R; Henry, B	1
Bercot, B; Bernier, J; Bleibtreu, A; Chaibi, K; Contejean, A; Cuzon, G; Delory, T; El Alaoui, F; Escaut, L; Joseph, A; Lafaurie, M; Maillard, A; Molina, JM; Paccoud, O; Poupet, H; Robert, J; Surgers, L; Tankovic, J; Villa, A	1
Cao, SS; Cui, B; Cui, F; Cui, J; Fan, BY; Fan, TT; Guan, Y; Ji, B; Li, MY; Li, SR; Wang, JW; Wang, L; Yan, CY; Zhang, W	1
Fujimi, S; Ogura, H; Tanaka, Y; Umemura, Y; Yamakawa, K; Yoshimura, J	1
Chen, M; Feng, N; Guo, W; Hu, J; Ju, M; Qian, Y; Yang, S	1
Ávila-Núñez, M; Celestino, P; García-Formoso, L; Garrido-Ventín, M; Lima, O; Martinez-Lamas, L; Pérez-Landeiro, A; Pérez-Rodríguez, MT; Represa, M; Rubianes, M; Rubiñán, P; Sousa, A; Vasallo-Vidal, F	1

Reviews

10 review(s) available for carbapenems and piperacillin, tazobactam drug combination

Article	Year
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surgical infections, 2000, Volume: 1, Issue:1 Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin	2000
Escherichia coli sequence type 131: epidemiology and challenges in treatment. Expert review of anti-infective therapy, 2014, Volume: 12, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States	2014
Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms. Journal of clinical microbiology, 2018, Volume: 56, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Clinical Decision-Making; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination	2018
Risk factors for hospitalized patients with resistant or multidrug-resistant Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin	2018
Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic review. Acta anaesthesiologica Scandinavica, 2019, Volume: 63, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Piperacillin, Tazobactam Drug Combination	2019
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors? Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam	2020
Comparison of Duration and Empiric Antibiotic Choice of Post-Operative Treatment in Abdominal Sepsis. Surgical infections, 2022, Volume: 23, Issue:5 Topics: Anti-Bacterial Agents; Carbapenems; Humans; Intraabdominal Infections; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis	2022
Controversies over the management of infections caused by Amp-C- and ESBL-producing Enterobacterales : what questions remain for future studies? Current opinion in infectious diseases, 2022, 12-01, Volume: 35, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination	2022
Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tazobactam	2022
Piperacillin/tazobactam versus carbapenems in patients with severe bacterial infections: A systematic review with meta-analysis. Acta anaesthesiologica Scandinavica, 2023, Volume: 67, Issue:7 Topics: Adult; Bacteria; Bacterial Infections; Carbapenems; Coinfection; Humans; Piperacillin, Tazobactam Drug Combination; Quality of Life	2023

Trials

3 trial(s) available for carbapenems and piperacillin, tazobactam drug combination

Article	Year
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Pediatric hematology and oncology, 2008, Volume: 25, Issue:4 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2008
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult	2010
Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis. Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2022

Other Studies

74 other study(ies) available for carbapenems and piperacillin, tazobactam drug combination

Article	Year
Resistance patterns of Pseudomonas aeruginosa to carbapenems and piperacillin/tazobactam. Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:2 Topics: Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Incidence; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Risk Factors	1999
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2007, Volume: 39, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors	2007
Trends in antibacterial use in US academic health centers: 2002 to 2006. Archives of internal medicine, 2008, Nov-10, Volume: 168, Issue:20 Topics: Academic Medical Centers; Adult; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States; Vancomycin	2008
Efficacy of intravenous infusion of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated	2009
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. The new microbiologica, 2009, Volume: 32, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Imipenem; Iran; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins	2009
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic	2010
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence	2010
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult	2010
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa	2011
Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagnostic microbiology and infectious disease, 2011, Volume: 69, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood; Canada; Candida; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Fungal; Emergency Service, Hospital; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Patients' Rooms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Prevalence; Sepsis	2011
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2016
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections	2012
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. The Journal of international medical research, 2013, Volume: 41, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline	2013
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia. Infection control and hospital epidemiology, 2014, Volume: 35, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome	2014
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2014, Volume: 30, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Drug Resistance; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins	2014
Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis. Diagnostic microbiology and infectious disease, 2014, Volume: 80, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Survival Analysis; Treatment Outcome	2014
Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, May-01, Volume: 60, Issue:9 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cohort Studies; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Proportional Hazards Models; Proteus mirabilis; Survival Rate; Time Factors	2015
Clinical Impact of Discordant Prescribing of Fluoroquinolones and Alternative Treatments in Escherichia coli Pyelonephritis. Journal of pharmacy practice, 2016, Volume: 29, Issue:5 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Guidelines as Topic; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Treatment Outcome	2016
Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colony Count, Microbial; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Microbial Sensitivity Tests; Mutation Rate; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; RNA, Messenger	2015
Epidemiology of antimicrobial resistance in an oncology center in eastern India. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:7 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts	2015
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections	2015
Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Female; Hospital Mortality; Humans; Male; Middle Aged; Needs Assessment; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Prognosis; Pseudomonas Infections	2015
Patient and physician predictors of patient receipt of therapies recommended by a computerized decision support system when initially prescribed broad-spectrum antibiotics: a cohort study. Journal of the American Medical Informatics Association : JAMIA, 2016, Volume: 23, Issue:e1 Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Decision Support Systems, Clinical; Drug Therapy, Computer-Assisted; Drug Utilization; Female; Guideline Adherence; Humans; Inappropriate Prescribing; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Patient Admission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Singapore	2016
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. PloS one, 2016, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Female; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies	2016
Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:8 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tokyo	2016
Proposed breakpoint of piperacillin/tazobactam against extended spectrum β-lactamases producing bacteria in bacteremia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Female; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam	2017
Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ open, 2016, 11-03, Volume: 6, Issue:11 Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Hospitalized; Child, Preschool; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization; Female; Health Care Surveys; Hospitalization; Hospitals; Humans; Inappropriate Prescribing; Infant; Male; Pediatrics; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; State Medicine; Surveys and Questionnaires; United Kingdom	2016
Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009. Anaerobe, 2017, Volume: 43 Topics: Anti-Infective Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Bacteroidetes; beta-Lactamase Inhibitors; Carbapenems; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States	2017
Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital. Anaerobe, 2017, Volume: 43 Topics: Anaerobiosis; Anti-Infective Agents; Bacteremia; Bacteria, Anaerobic; Bacteroides; Carbapenems; Clindamycin; Clostridium; Drug Resistance, Microbial; Fusobacterium; Gram-Positive Bacteria; Humans; Intraabdominal Infections; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propionibacterium; Retrospective Studies	2017
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Journal of medical microbiology, 2017, Volume: 66, Issue:1 Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections	2017
Clinical features and antimicrobial resistance profiles of important Enterobacteriaceae pathogens in Guangzhou representative of Southern China, 2001-2015. Microbial pathogenesis, 2017, Volume: 107 Topics: Amikacin; Anti-Bacterial Agents; Blood; Carbapenems; Ceftazidime; Cephalosporins; China; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sputum; Urinary Tract	2017
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece. Future microbiology, 2017, Volume: 12 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline	2017
Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship team. International journal of antimicrobial agents, 2017, Volume: 50, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Communicable Diseases; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult	2017
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study. BMC infectious diseases, 2017, 07-17, Volume: 17, Issue:1 Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins	2017
Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study. Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; France; Glycopeptides; Guidelines as Topic; Hospitals; Humans; Intensive Care Units; Logistic Models; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Prescriptions; Probability; Retrospective Studies	2018
Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents. Die Pharmazie, 2017, May-01, Volume: 72, Issue:5 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Hospital Mortality; Hospitalization; Humans; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Services; Pharmacists; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcal Infections	2017
A national quality incentive scheme to reduce antibiotic overuse in hospitals: evaluation of perceptions and impact. The Journal of antimicrobial chemotherapy, 2018, 06-01, Volume: 73, Issue:6 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Drug Prescriptions; Drug Utilization; Hospitalization; Hospitals; Humans; Motivation; National Health Programs; Piperacillin, Tazobactam Drug Combination; Quality Improvement; Surveys and Questionnaires; United Kingdom	2018
Gram negative anaerobe susceptibility testing in clinical isolates using Sensititre and Etest methods. Pathology, 2018, Volume: 50, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2018
Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia. International journal of antimicrobial agents, 2018, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Humans; Invasive Pulmonary Aspergillosis; Piperacillin, Tazobactam Drug Combination; Prospective Studies	2018
The impact of earlier intervention by an antimicrobial stewardship team for specific antimicrobials in a single weekly intervention. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 77 Topics: Anti-Infective Agents; Antimicrobial Stewardship; Carbapenems; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Teicoplanin; Time Factors; Treatment Outcome; Vancomycin	2018
Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study. Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Colistin; Communicable Diseases; Cost-Benefit Analysis; Drug Utilization; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Saudi Arabia; Tertiary Care Centers; Vancomycin; Young Adult	2018
Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients. Journal of Korean medical science, 2019, Jan-14, Volume: 34, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Febrile Neutropenia; Humans; Piperacillin, Tazobactam Drug Combination	2019
Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients. International journal of antimicrobial agents, 2019, Volume: 53, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Scotland; Tazobactam; Whole Genome Sequencing	2019
A Combination Antibiogram Evaluation for Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States	2019
Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study. Internal medicine (Tokyo, Japan), 2019, Sep-15, Volume: 58, Issue:18 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin; Young Adult	2019
Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae. PloS one, 2019, Volume: 14, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Citrobacter freundii; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Plasmids; Serratia marcescens	2019
Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections. Medecine et maladies infectieuses, 2020, Volume: 50, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cohort Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Observational Studies as Topic; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic	2020
Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae. The Journal of antimicrobial chemotherapy, 2020, 02-01, Volume: 75, Issue:2 Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Urinary Tract Infections	2020
Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems. International journal of antimicrobial agents, 2020, Volume: 55, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies	2020
Emergence of Resistance to Carbapenems Should Not Be Considered the Only Marker of Good Practices in Antibiotic Stewardship. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-03, Volume: 71, Issue:9 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamases; Carbapenems; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis	2020
Is Piperacillin-Tazobactam Really Comparable to Carbapenem for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-03, Volume: 71, Issue:9 Topics: beta-Lactamases; Carbapenems; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis	2020
Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study. Annals of clinical microbiology and antimicrobials, 2020, Feb-17, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefepime; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Young Adult	2020
Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017. Medicine, 2020, Volume: 99, Issue:8 Topics: Age Distribution; Anti-Bacterial Agents; Carbapenems; Ceftazidime; Child, Preschool; China; Clavulanic Acids; Comorbidity; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Immunosuppressive Agents; Infant; Intensive Care Units, Pediatric; Length of Stay; Male; Piperacillin, Tazobactam Drug Combination; Respiration, Artificial; Retrospective Studies; Risk Factors; Sex Distribution; Stenotrophomonas maltophilia; Surgical Procedures, Operative; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination	2020
The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia. Anaerobe, 2020, Volume: 64 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Bacteria, Anaerobic; Carbapenems; Female; Hospitals, University; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prognosis; Treatment Outcome	2020
A retrospective observational study of antibiotics treatment for sepsis using a nationwide claim database in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:11 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Humans; Japan; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis	2020
Evaluation of First-Dose, Intravenous Push Penicillins and Carbapenems in the Emergency Department. Journal of pharmacy practice, 2022, Volume: 35, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; Carbapenems; Emergency Service, Hospital; Ertapenem; Humans; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sulbactam	2022
Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies. Hematology (Amsterdam, Netherlands), 2021, Volume: 26, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Disease-Free Survival; Female; Glycopeptides; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Young Adult	2021
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience. Microbial drug resistance (Larchmont, N.Y.), 2021, Volume: 27, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carbapenems; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; SARS-CoV-2; Steroids; Survival Analysis; Treatment Outcome	2021
Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study. Journal of infection and public health, 2021, Volume: 14, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Female; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Superinfection; Treatment Outcome	2021
Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Propensity Score; Retrospective Studies	2021
Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospital. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:7 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Fluoroquinolones; Hospitals; Humans; Japan; Levofloxacin; Meropenem; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa	2022
A nationwide evaluation of antibiotics consumption in Swedish intensive care units. Infectious diseases (London, England), 2022, Volume: 54, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Humans; Intensive Care Units; Piperacillin, Tazobactam Drug Combination; Sweden	2022
Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model. The Journal of antimicrobial chemotherapy, 2022, 08-25, Volume: 77, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2022
Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan. The American journal of tropical medicine and hygiene, 2022, 08-17, Volume: 107, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Doripenem; Escherichia coli; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Taiwan; Tertiary Care Centers	2022
Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis. The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis	2022
Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa. Scientific reports, 2022, 10-07, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Monobactams; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Piperacillin/Tazobactam Dose Optimization in the Setting of Piperacillin/Tazobactam-susceptible, Carbapenem-resistant Pseudomonas aeruginosa: Time to Reconsider Susceptible Dose Dependent. Clinical therapeutics, 2023, Volume: 45, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Mitomycin; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Tazobactam	2023
Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients. The Journal of antimicrobial chemotherapy, 2023, 04-03, Volume: 78, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cefoxitin; Citrobacter freundii; Enterobacter aerogenes; Enterobacter cloacae; Humans; Microbial Sensitivity Tests; Morganella morganii; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Serratia marcescens	2023
Which trial do we need? Piperacillin-tazobactam compared with a carbapenem for treatment of graft pyelonephritis caused by extended spectrum β-lactamase-producing Enterobacteriaceae. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:7 Topics: beta-Lactamases; Carbapenems; Enterobacteriaceae; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis	2023
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study. International journal of antimicrobial agents, 2023, Volume: 62, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies	2023
Efficacy and safety of piperacillin-tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Urinary Tract Infections	2023
Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study. Critical care medicine, 2023, 09-01, Volume: 51, Issue:9 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Hospital Mortality; Humans; Monobactams; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Treatment Outcome	2023
Prevalence and risk factors for severe linezolid-associated thrombocytopenia in pediatric patients: An analysis of a public database. Medicine, 2023, Jun-16, Volume: 102, Issue:24 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Child; Humans; Linezolid; Piperacillin, Tazobactam Drug Combination; Platelet Count; Prevalence; Retrospective Studies; Risk Factors; Thrombocytopenia	2023
Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales. Annals of clinical microbiology and antimicrobials, 2023, Aug-17, Volume: 22, Issue:1 Topics: Adult; Aged; Bacteremia; Carbapenems; Cefepime; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis	2023